Original language | English (US) |
---|---|
Pages (from-to) | 1548-1552 |
Number of pages | 5 |
Journal | Movement Disorders |
Volume | 36 |
Issue number | 7 |
DOIs |
|
State | Published - Jul 2021 |
Funding
Puneet Opal declares no conflicts of interest with this review. He currently receives funding from the Hannah's Hope Fund and the Muscular Dystrophy Association for projects involving giant axonal neuropathy. He is performing a research study with the pharmaceutical company Biohaven on SCAs. He receives royalties from Uptodate. Chandrakanth R. Edamakanti declares no conflicts of interest and no funding from any institution, including personal relationships, interests, grants, employment, affiliations, patents, inventions, honoraria, consultancies, royalties, stock options/ownership, or expert testimony for the past 12 months. C.R.E. receives support from the National Ataxia Foundation through a young investigator grant in spinocerebellar ataxia (YISCA) and from Northwestern University Clinical and Translational Sciences (NUCATS) & Northwestern Memorial Foundation (NMF) through DIXON TRANSLATIONAL RESEARCH GRANTS INITIATIVE in new Investigator catagory. P.O. receives support from the National Institutes of Health (1R01NS062051, 1R01NS082351, and R56NS108639).
ASJC Scopus subject areas
- Clinical Neurology
- Neurology